✦ LIBER ✦

Carboplatin plus gemcitabine as first-line treatment in eldelry patients with non-small-cell lung cancer: Preliminary results of a multicenter phase ii trial by the Hellenic Oncology Researsch Group (HORG)

✍ Scribed by Vamvakas, L.; Karampeazis, A.; Agelaki, S.; Kentepozidis, N.; Polyzos, A.; Kotsakis, A.; Kalbakis, K.; Christofyllakis, C.; Kontopodis, E.; Pallis, A.G.; Georgoulias, V.

Book ID: 122118539
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 48 KB
Volume: 4
Category: Article
ISSN: 1879-4068
DOI: 10.1016/j.jgo.2013.09.039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and gemcitabine combination, a

Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group

✍ Skarlos, Dimosthenis-Vasilios; Dimopoulos, Athanassios-Meletios; Kosmidis, Paras 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 160 KB

1150 POSTER First line chemotherapy with

1150 POSTER First line chemotherapy with docetaxel plus gemcitabine in elderly or poor performance status patients with advanced non-small cell lung cancer: The experience of the hellenic oncology research group (HORG)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A phase II trial of weekly chemotherapy

A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Hiroyuki Kobayashi; Yukari Kamiyama; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 268 KB

Results of a phase II multicenter trial

Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

✍ Neubauer, Marcus A.; Garfield, David H.; Kuerfler, Paul R.; Raju, Robert N.; Lin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Paclitaxel plus bevacizumab in patients

Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group

✍ Mountzios, Giannis; Emmanouilidis, Christos; Vardakis, Nikolaos; Kontopodis, Emm 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 222 KB

802 Multicenter phase II trial of weekly

802 Multicenter phase II trial of weekly Taxol and paraplatine as first line treatment in elderly patients with non small cell lung cancer (NSCLC): preliminary results

✍ J.-L. Pujol; B. Milleron; E. Quoix; A. Depierre; J.-L. Breton; R. Gervais; D. De 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB